Clinical trial
Feasibility Study of CDDP + CPT-11 + PSK for Extensive-Stage Disease (ED) Small Cell Lung Cancer
NCT00546130
Study timeline
Study start (unknown)2007-11-01Date precision: month
Registry last updated2008-09-03
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Small Cell Lung Cancerunresolved
Interventions
Irinotecan hydrochlorideDRUG · verified · RxNorm: irinotecan hydrochloride
CisplatinDRUG · verified · RxNorm: cisplatin
KrestinDRUG
Sponsors & collaborators
University of Toyamalead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00546130 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.